HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Presence of HLA-DRB1 alleles in a group of patients with rheumatoid arthritis treated with low doses of sodium aurothiomalate].

Abstract
The good results of a therapy with small doses of sodium aurothiomalate (20 mg/month) in 17 patients suffering from rheumatoid arthritis are reported. The mean age +/- ESM at the beginning of treatment was 59.9 +/- 3.2 years, the mean duration of disease was 1.3 +/- 0.5 years. The lowest grade of disease activity (1) according to Mallya and Mace's (1981) criteria was observed in 12 patients (70%) after a period of 1.7 +/- 0.6 years (mean +/- ESM). This grade of activity persisted in 11 patients and remained for 3 years in 1 patient. In the other 5 patients a low or middle activity of disease persisted. The relationship between therapeutic results and HLA DRB1 prevalence was investigated. The LLEQRRAA and LLEQKRAA sequences are present in 3 patients, i.e. 17.9%. This frequency is not significantly different from the frequency (28.6%) observed in a control group of healthy subjects. Therefore these sequences, at least in Italian people, cannot be considered a factor of susceptibility to RA. They may be a factor of evolution to a more severe disease. Dermatological side effects were evident only in 2 patients; one of these patients was HLA DR5 positive. The results observed in DR7 positive patients were not different from the results observed in the other patients; therefore, DR7 positive patients could responders to gold treatment, even with low doses.
AuthorsG Bianucci, G Rombolà, M Tringali, C Curradi, S M Bongi
JournalLa Clinica terapeutica (Clin Ter) Vol. 148 Issue 12 Pg. 577-92 (Dec 1997) ISSN: 0009-9074 [Print] Italy
Vernacular TitlePresenza degli alleli HLA DRB1 in un gruppo di pazienti con artrite reumatoide trattato con basse dosi di aurotiomalato di sodio.
PMID9528193 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Antirheumatic Agents
  • HLA-DR Antigens
  • HLA-DRB1 Chains
  • Gold Sodium Thiomalate
Topics
  • Adult
  • Age Factors
  • Aged
  • Alleles
  • Amino Acid Sequence
  • Antirheumatic Agents (administration & dosage)
  • Arthritis, Rheumatoid (drug therapy, genetics)
  • Data Interpretation, Statistical
  • Evaluation Studies as Topic
  • Female
  • Gold Sodium Thiomalate (administration & dosage)
  • HLA-DR Antigens (genetics)
  • HLA-DRB1 Chains
  • Humans
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: